Prognostic Value of Health Status in Patients With Heart Failure After Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Prognostic Value of Health Status in Patients With Heart Failure After Acute Myocardial Infarction

Published:2004-08-03 Issue:5 Volume:110 Page:546-551
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Soto Gabriel E.¹,Jones Philip¹,Weintraub William S.¹,Krumholz Harlan M.¹,Spertus John A.¹

Affiliation:

1. From the Washington University School of Medicine, St Louis, Mo (G.E.S.); Mid America Heart Institute and University of Missouri, Kansas City (P.J., J.A.S.); Emory University, Atlanta, Ga (W.S.W.); and Yale University, New Haven, Conn (H.M.K.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference13 articles.

1. Heart failure: Evaluation and care of patients with left ventricular systolic dysfunction

2. Physician Consortium for Performance Improvement. Clinical performance measures in heart failure: a consensus document from the ACC AHA and the Consortium. Available at: http://www.ama-assn.org/go/quality. Accessed February 1 2004.

3. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure

4. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

5. Expanding the outcomes in clinical trials of heart failure: The quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal efficacy and survival study)

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan;Pharmacia;2024-06-27

2. Predictive value of quality of life as measured by KCCQ in heart failure patients: A meta‐analysis;European Journal of Clinical Investigation;2024-04-26

3. Evaluating the efficacy and safety of mavacamten in hypertrophic cardiomyopathy: A systematic review and meta-analysis focusing on qualitative assessment, biomarkers, and cardiac imaging;PLOS ONE;2024-04-18

4. Health economic evaluation of blended collaborative care for older multimorbid heart failure patients: study protocol;Cost Effectiveness and Resource Allocation;2024-04-13

5. Advances in management of heart failure;BMJ;2024-04-10